You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

NYSTATIN - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for nystatin and what is the scope of freedom to operate?

Nystatin is the generic ingredient in seventeen branded drugs marketed by Bayer Pharms, Delcor Asset Corp, Alpharma Us Pharms, Lederle, Actavis Mid Atlantic, Cosette, Crown Labs Inc, Fougera Pharms, Macleods Pharms Ltd, Padagis Us, Strides Pharma, Taro, Torrent, Lyne, Zydus Lifesciences, Barlan, Paddock Llc, Adrastea Pharma, Dr Reddys Labs Sa, Epic Pharma Llc, Lupin, Nesher Pharms, Upsher Smith Labs, Zydus Pharms, Warner Chilcott, Chartwell Molecules, Fougera Pharms Inc, G And W Labs Inc, Genus, Leading, MLV, Morton Grove, Pai Holdings, Pharm Assoc, Pharmaderm, Pharmafair, Teva, Vistapharm, Wockhardt Bio Ag, Savage Labs, Chartwell Rx, Heritage, Quantum Pharmics, Sandoz, Sun Pharm Industries, Watson Labs, Holland Rantos, Fougera, Odyssey Pharms, Mylan, Alembic, Amneal, Dr Reddys, Glenmark Pharms Ltd, Lupin Ltd, Padagis Israel, Perrigo New York, Pai Holdings Pharm, and Rising, and is included in one hundred and twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for nystatin. Forty-one suppliers are listed for this compound.

Summary for NYSTATIN

US Patents:	0
Tradenames:	17
Applicants:	59
NDAs:	121
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	41
Raw Ingredient (Bulk) Api Vendors:	41
Clinical Trials:	38
Patent Applications:	7,269
Drug Prices:	Drug price trends for NYSTATIN
Drug Sales Revenues:	Drug sales revenues for NYSTATIN
What excipients (inactive ingredients) are in NYSTATIN?	NYSTATIN excipients list
DailyMed Link:	NYSTATIN at DailyMed

Drug Prices for NYSTATIN

See drug prices for NYSTATIN

Drug Sales Revenue Trends for NYSTATIN

See drug sales revenues for NYSTATIN

Recent Clinical Trials for NYSTATIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Santiago de Compostela	N/A
University of Rochester	Phase 1
Minia University	Early Phase 1

See all NYSTATIN clinical trials

Pharmacology for NYSTATIN

Drug Class	Polyene Antifungal

Medical Subject Heading (MeSH) Categories for NYSTATIN

Anti-Bacterial Agents
Antifungal Agents
Ionophores

US Patents and Regulatory Information for NYSTATIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Padagis Us	NYSTATIN	nystatin	CREAM;TOPICAL	062225-001	Approved Prior to Jan 1, 1982	AT	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharmaderm	NYSTATIN	nystatin	TABLET;VAGINAL	062460-001	Nov 9, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Molecules	NILSTAT	nystatin	SUSPENSION;ORAL	050299-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dr Reddys	NYSTATIN AND TRIAMCINOLONE ACETONIDE	nystatin; triamcinolone acetonide	CREAM;TOPICAL	208326-001	Oct 26, 2016	AT	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Delcor Asset Corp	MYCOSTATIN	nystatin	SUSPENSION;ORAL	061533-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.